Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia

Author:

Sheikh Virginia1ORCID,Porter Brian O.1,DerSimonian Rebecca1,Kovacs Stephen B.2,Thompson William L.1,Perez-Diez Ainhoa1,Freeman Alexandra F.1,Roby Gregg1,Mican JoAnn1,Pau Alice1,Rupert Adam2,Adelsberger Joseph2,Higgins Jeanette2,Bourgeois Jeffrey S.1,Jensen Stig M. R.1,Morcock David R.3,Burbelo Peter D.4,Osnos Leah1,Maric Irina5,Natarajan Ven2,Croughs Therese6,Yao Michael D.1,Estes Jacob D.3,Sereti Irini1

Affiliation:

1. National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD;

2. Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD;

3. AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD;

4. Dental Clinical Research Core, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD;

5. Hematology Section, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD; and

6. Cytheris Inc., Subsidiary of Cytheris S.A., Issy les Moulineaux, France

Abstract

Key Points rhIL-7 therapy was well tolerated in patients with ICL. rhIL-7 led to increases in CD4 T cells in both peripheral blood and tissues.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3